Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Other hematologic neoplasm 1 Gynecologic 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 905 Cyclophosphamide 899 fludarabine 525 venetoclax 489 fludarabine phosphate 468 Azacitidine 460 Rituximab 431 Methotrexate 419 Etoposide 320 Filgrastim 299 Busulfan 296 Dexamethasone 286 Vincristine 285 Daunorubicin 283 Peripheral Blood Stem Cell Transplantation 258 Whole-Body Irradiation 243 Mycophenolic Acid 232 Decitabine 230 Granulocyte Colony-Stimulating Factor 227 Tacrolimus 220 Imatinib Mesylate 211 Idarubicin 205 Melphalan 202 Cyclosporine 182 Doxorubicin 177 Radiotherapy 169 Prednisone 164 Dasatinib 163 Mitoxantrone 161 Lenalidomide 160

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Atovaquone × Other hematologic neoplasm × Clear all

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡